Experimental and Computational Assessment of the Role of NOX4 in Mitochondrial Dysfunction Associated with ARDS

NOX4 在 ARDS 相关线粒体功能障碍中作用的实验和计算评估

基本信息

  • 批准号:
    10579495
  • 负责人:
  • 金额:
    $ 44.57万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-07-01 至 2025-06-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Acute Respiratory Distress Syndrome (ARDS) is a life-threatening disorder characterized by refractory hypox- emia. Inciting lung injury results in damage to pulmonary endothelial and epithelial cells causing vascular hyper- permeability and edema. A wealth of information exists regarding the effect of ARDS on specific cellular pro- cesses, including ample evidence of a key role for oxidative stress in its initiation, with mitochondria as a primary target. However, the sources of reactive oxygen species (ROS) and the mechanisms by which oxidative stress induces mitochondrial dysfunction in ARDS are poorly understood. Furthermore, a mechanistic and quantitative framework for integrating new and existing bioenergetic data acquired at different biological scales to ascertain their functional implications is lacking. Our proposed work addresses these important knowledge gaps. NOX4, an NADPH oxidase isoform, is unique in that its rate of ROS production is dependent on cellular oxygen (O2) concentration. This is important since a primary therapy for patients with ARDS is provision of high fractions of O2, and rat exposure to high fractions of inspired O2 (hyperoxia) is a model of human ARDS. With O2-depend- ent ROS kinetics, NOX4 is a strong candidate to initiate or amplify lung injury. Activation of NOX4 can also increase mitochondrial ROS production and vice-versa, resulting in an apparent crosstalk between these two important ROS sources and a positive feedback cycle. This can lead to mitochondrial damage and release of pro-inflammatory mitochondrial damage-associated molecular patterns, which in turn can stimulate inflammation and cell death, increase vascular permeability, and can ultimately result in edema, a cardinal feature of ARDS. Motivated by our strong preliminary and published data, our overall hypothesis is that NOX4 is an essential driver of oxidative stress that induces mitochondrial dysfunction, and that altered mitochondrial bioenergetics is a key pathway in the pathogenesis of ARDS. Using a powerful combination of vertically integrated experimental approaches, a unique NOX4 knockout (KO) rat model, and two models of human ARDS (hyperoxia and intratra- cheal lipopolysaccharide), our data will address NOX4’s role in oxidative stress and mitochondrial dysfunction that characterize ARDS. A large-scale computational model will provide a quantitative framework for integrating data acquired at different biological scales to ascertain the functional implications of a change in specific mito- chondrial and cytosolic processes altered in ARDS, including those differentially altered between NOX4 KO and WT rats. Thus, the specific aims are to 1) demonstrate the essential role of NOX4-generated ROS in mitochon- drial dysfunction and microvascular hyperpermeability that characterize ARDS, and 2) develop a mechanistic computational model of lung tissue bioenergetics for predicting functional implications of alterations in mitochon- drial processes. The key outcomes are i) a mechanistic and quantitative understanding of the role of NOX4 in modifying mitochondrial function in ARDS, and ii) a comprehensive computational model for integrating bioen- ergetics data and for identifying potential therapeutic targets to protect against ARDS or mitigate its progression.
项目摘要 急性呼吸窘迫综合征(ARDS)是一种威胁生命的障碍 EMIA煽动肺肺 渗透性和水肿存在大量有关ARD对特定细胞的影响 塞斯(Cesses 但是,反应性氧(ROS)的来源和氧化应激的机制 ARDS中诱导的Mitchondrial功能障碍的理解很差。 集成在不同生物群中获取新的和现有的生物能数据以确定的框架 他们的功能含义缺乏我们的支撑工作解决这些知识差距。 NADPH氧化酶同工型NOX4是独特的,因为ROS产生的速率取决于细胞氧气 (O2)浓度。 O2和大鼠暴露于启发的O2(高氧)是人类ARD的模型。 NOX4是Int Ros Kinetics,是Innitation或Amplify Lung Inn的强大候选者。 增加Mitchondrial ROS的产生,反之亦然,导致两个之间的明显crostalk 重要的ROS来源和正反馈周期。 促炎性线粒体损伤相关的分子模式,进而刺激炎症 和细胞死亡,增加血管渗透性,并迅速导致水肿,这是ARDS的主要特征。 由我们的鲜明和发布的数据激励 诱导线粒体功能障碍的氧化应激驱动器,并且改变了米孔氏菌生化的驱动力是 ARDS的发病机理中的关键途径。 方法,独特的NOX4敲除(KO)大鼠模型,以及两个人类ARD的模型(高氧和内部 - CHEAL脂质菌糖),我们的数据将解决氧化应激和线粒体功能障碍的NOLE 这是ards的特征。 在不同的生物量表中获取的数据,以确定特定Mito-变化的功能意义含义 软骨和细胞性过程在ARDS中发生了变化 WT大鼠。因此,具体的目的是1) 表征ARD的Drial功能障碍和微血管高透明性,2)发展机械 肺组织生物能学的计算模型,用于预测线形变化的功能实施 Drial过程。 修改ARDS中的Mitchondrial功能,ii)一个综合的计算模型,用于整合生物基 精神分析数据以及识别潜在的治疗剂以防止ARDS或减轻ARDS是进步。

项目成果

期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Biomarkers for Radiation Pneumonitis Using Noninvasive Molecular Imaging.
Assessment of Protection Offered By the NRF2 Pathway Against Hyperoxia-Induced Acute Lung Injury in NRF2 Knockout Rats.
  • DOI:
    10.1097/shk.0000000000001882
  • 发表时间:
    2022-02-01
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Audi SH;Jacobs ER;Taheri P;Ganesh S;Clough AV
  • 通讯作者:
    Clough AV
Protection by Inhaled Hydrogen Therapy in a Rat Model of Acute Lung Injury can be Tracked in vivo Using Molecular Imaging.
  • DOI:
    10.1097/shk.0000000000000872
  • 发表时间:
    2017-10
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Audi SH;Jacobs ER;Zhang X;Camara AKS;Zhao M;Medhora MM;Rizzo B;Clough AV
  • 通讯作者:
    Clough AV
Integrated Computational Model of Lung Tissue Bioenergetics.
肺组织生物能学的综合计算模型。
  • DOI:
    10.3389/fphys.2019.00191
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    4
  • 作者:
    Zhang,Xiao;Dash,RanjanK;Clough,AnneV;Xie,Dexuan;Jacobs,ElizabethR;Audi,SaidH
  • 通讯作者:
    Audi,SaidH
Lung injury pathways: Adenosine receptor 2B signaling limits development of ischemic bronchiolitis obliterans organizing pneumonia.
  • DOI:
    10.1080/01902148.2017.1286697
  • 发表时间:
    2017-03
  • 期刊:
  • 影响因子:
    1.7
  • 作者:
    Densmore JC;Schaid TR;Jeziorczak PM;Medhora M;Audi S;Nayak S;Auchampach J;Dwinell MR;Geurts AM;Jacobs ER
  • 通讯作者:
    Jacobs ER
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SAID H AUDI其他文献

SAID H AUDI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SAID H AUDI', 18)}}的其他基金

Lung Metabolism: Multiple Indicator Dilution
肺代谢:多指标稀释
  • 批准号:
    7880619
  • 财政年份:
    1979
  • 资助金额:
    $ 44.57万
  • 项目类别:
Lung Metabolism: Multiple Indicator Dilution
肺代谢:多指标稀释
  • 批准号:
    7319030
  • 财政年份:
    1979
  • 资助金额:
    $ 44.57万
  • 项目类别:
Lung Metabolism: Multiple Indicator Dilution
肺代谢:多指标稀释
  • 批准号:
    7619155
  • 财政年份:
    1979
  • 资助金额:
    $ 44.57万
  • 项目类别:
Lung Metabolism: Multiple Indicator Dilution
肺代谢:多指标稀释
  • 批准号:
    7455881
  • 财政年份:
    1979
  • 资助金额:
    $ 44.57万
  • 项目类别:
LUNG METABOLISM--MULTIPLE INDICATOR DILUTION
肺代谢--多指标稀释
  • 批准号:
    6619562
  • 财政年份:
    1979
  • 资助金额:
    $ 44.57万
  • 项目类别:
LUNG METABOLISM--MULTIPLE INDICATOR DILUTION
肺代谢--多指标稀释
  • 批准号:
    6793179
  • 财政年份:
    1979
  • 资助金额:
    $ 44.57万
  • 项目类别:

相似国自然基金

蜗牛粘液糖胺聚糖影响中性粒细胞粘附和迁移在治疗急性呼吸窘迫综合征中的作用研究
  • 批准号:
    82360025
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
锌离子转运蛋白SLC39A1在急性呼吸窘迫综合征中的作用和机制
  • 批准号:
    32371177
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
特络细胞源性外泌体经JAK/STAT-miRNA-E2F轴修复肺血管改善急性呼吸窘迫综合征的机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目
线粒体环形孔道释放ox-mtDNA引起肺泡巨噬细胞焦亡及HMGB1分泌致脓毒症相关急性呼吸窘迫综合征的机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
探索在急性呼吸窘迫综合征动物模型和患者长时间俯卧位通气过程中动态滴定呼气末正压的意义
  • 批准号:
    82270081
  • 批准年份:
    2022
  • 资助金额:
    76 万元
  • 项目类别:
    面上项目

相似海外基金

Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
  • 批准号:
    10648387
  • 财政年份:
    2023
  • 资助金额:
    $ 44.57万
  • 项目类别:
Understanding and targeting fibroblast activation in influenza-triggered lung inflammation and post-viral disease
了解和靶向流感引发的肺部炎症和病毒后疾病中的成纤维细胞激活
  • 批准号:
    10717809
  • 财政年份:
    2023
  • 资助金额:
    $ 44.57万
  • 项目类别:
MLL1 drives collaborative leukocyte-endothelial cell signaling and thrombosis after coronavirus infection
MLL1在冠状病毒感染后驱动白细胞-内皮细胞信号传导和血栓形成
  • 批准号:
    10748433
  • 财政年份:
    2023
  • 资助金额:
    $ 44.57万
  • 项目类别:
LOX-1 as a protective countermeasure in response to lung infection
LOX-1 作为应对肺部感染的保护性对策
  • 批准号:
    10677924
  • 财政年份:
    2023
  • 资助金额:
    $ 44.57万
  • 项目类别:
The Intermountain West-Atlantic Center (InterACT) for the APS Phenotyping Consortium
APS 表型联盟的山间西大西洋中心 (InterACT)
  • 批准号:
    10649343
  • 财政年份:
    2023
  • 资助金额:
    $ 44.57万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了